Panel Reactive Antibody (PRA) Identification By Luminex (Class I) in Bangalore
50+ booked in last 3 daysOverview
A panel-reactive antibody (PRA) is a group of antibodies in the serum of patient that are reactive against several known specific antigens in a panel of test cells or purified HLA antigens from donors.
Panel Reactive Antibody (PRA) Identification By Luminex (Class I) Price in Bangalore
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Panel Reactive Antibody (PRA) Identification By Luminex (Class I) with a clear pricing structure
The price of Panel Reactive Antibody (PRA) Identification By Luminex (Class I) in Bangalore is ₹ 10,355
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
To detect the HLA class II specific antibodies in recipient serum against the donors’ panel
Performed for patients awaiting organ transplantation to identify sensitized patients.
A panel-reactive antibody (PRA) is a group of antibodies in the serum of patient that are reactive against several known specific antigens in a panel of test cells or purified HLA antigens from donors. It is an immunologic test routinely performed by clinical laboratories on the blood of people awaiting organ transplantation. The PRA score is expressed as a percentage between 0% and 100%. it quantifies the risk of transplant rejection.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.